TI
AKBA icon

Trexquant Investment’s Akebia Therapeutics AKBA Stock Holding History

Trexquant Investment’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-92,389
Closed -$700K – 1145
2020
Q1 		$700K Buy
+92,389
New +$719K 0.05% 533
2019
Q1 		– Sell
-54,593
Closed -$302K – 962
2018
Q4 		$302K Buy
+54,593
New +$427K 0.02% 777
2018
Q3 		– Sell
-35,822
Closed -$358K – 927
2018
Q2 		$358K Buy
+35,822
New +$359K 0.02% 630
2018
Q1 		– Sell
-21,102
Closed -$314K – 1041
2017
Q4 		$314K Buy
21,102
+3,496
+20% +$58K 0.03% 727
2017
Q3 		$346K Buy
+17,606
New +$271K 0.09% 412
2017
Q2 		– Sell
-17,220
Closed -$158K – 764
2017
Q1 		$158K Sell
17,220
-15,814
-48% -$154K 0.02% 997
2016
Q4 		$344K Buy
+33,034
New +$284K 0.05% 593
2016
Q3 		– Sell
-32,442
Closed -$243K – 711
2016
Q2 		$243K Buy
+32,442
New +$283K 0.03% 724
2016
Q1 		– Sell
-44,200
Closed -$571K – 886
2015
Q4 		$571K Sell
44,200
-28,300
-39% -$289K 0.05% 630
2015
Q3 		$700K Buy
+72,500
New +$665K 0.06% 583

Other funds holding AKBA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Trexquant Investment's AKBA Position: Q2 2020 in Review

Trexquant Investment sold out of Akebia Therapeutics (AKBA) in Q2 2020, closing a stake of 92,389 shares — an estimated $700K sold.

Trexquant Investment first reported a position in AKBA in Q3 2015 and held it in 10 quarters. The position peaked at $700K in Q1 2020. 189 funds tracked by Wall St. Rank hold AKBA as of Q2 2020.

  • Trexquant Investment reported no remaining Akebia Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Trexquant Investment sold 92,389 Akebia Therapeutics shares in Q2 2020, an estimated $700K.
  • Trexquant Investment first reported a position in Akebia Therapeutics in Q3 2015 and held it in 10 quarters.
  • Trexquant Investment's Akebia Therapeutics position peaked at $700K in Q1 2020.
  • 189 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2020.

Based on Trexquant Investment's 13F filing for Q2 2020, filed 7 Aug 2020.